Work

A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG Oncology/GOG study

Year: 2020

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2020.06.013

Authors: V.L. Bae-Jump, M. Sill, P.A. Gehrig, K. Moxley, A.R. Hagemann, S.E. Waggoner, R.E. O'Cearbhaill, M. McDonald, P.A. DiSilvestro, P. Sperduto, C. Aghajanian

Institutions: University of North Carolina at Chapel Hill, University of Oklahoma, Washington University in St. Louis, University Hospitals Cleveland Medical Center, Memorial Sloan Kettering Cancer Center, University of Iowa Hospitals and Clinics, Brown University

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3014080938

FWCI: 1.069

Cites:

Cited by: 20

Related to: 10